Latest News

Neurodegenerative disease advance: Study details how brain enzyme interacts with drug-like lead compound for Huntington's

A significant breakthrough has been made towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. Researchers have detailed how an enzyme in the brain interacts with a promising drug-like lead compound for Huntington's disease to inhibit its activity. Their findings demonstrate that it can be developed as an effective treatment for neurodegenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Depression as a risk factor for dementia: Link is independent of dementia-related brain changes

  • Popping pills to pushing needles: Prescription opioid abuse among young adults in NYC

  • Preterm children do not have an increased risk for dyscalculia, new research suggests

  • Management of anticoagulant-associated intracerebral hemorrhage

  • Benefits of e-cigarettes outweigh harms, current evidence suggests

  • New mapping approach lets scientists zoom in and out as the brain processes sound

  • Insular cortex alterations in mouse models of autism

  • Political attitudes derive from body and mind: 'Negativity bias' explains difference between liberals and conservatives

  • Study of twins discovers gene mutation linked to short sleep duration

  • First grade reading suffers in segregated schools

  •